Peter Ellman
Directeur Général chez Certis Oncology Solutions, Inc.
Profil
Peter Ellman is the founder of Nextec Applications, Inc. (founded in 1994).
He is currently the President, Chief Executive Officer & Director at Certis Oncology Solutions, Inc. Mr. Ellman previously worked as a Director at Stratagene Corp.
from 2006 to 2007.
Postes actifs de Peter Ellman
| Sociétés | Poste | Début |
|---|---|---|
Certis Oncology Solutions, Inc.
 Certis Oncology Solutions, Inc. BiotechnologyHealth Technology Certis Oncology Solutions, Inc. is a precision oncology and translational science company that partners with oncology therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. The company is based in San Diego, CA. The company uses their proprietary artificial intelligence/machine learning platform and more clinically relevant, patient-derived tumor models to bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy. Certis operates a CLIA-certified laboratory in Sorrento Valley, the heart of the life sciences industry. The company was founded in 2016, and the CEO is Peter Ellman. | Directeur Général | - |
Anciens postes connus de Peter Ellman
| Sociétés | Poste | Fin |
|---|---|---|
Stratagene Corp.
 Stratagene Corp. Medical SpecialtiesHealth Technology Stratagene Corp. researches, develops and markets diagnostic products and technologies for life science research. The company's products are used in the research of amplification, cell biology, cloning, microarrays, nucleic acid analysis, protein function and analysis, and quantitative PCR. Its clients include the industrial and government research sectors. The firm sells its products in more than 60 countries. Stratagene was founded in 1984 and is located in La Jolla, CA. | Directeur/Membre du Conseil | 08/06/2007 |
Nextec Applications, Inc.
 Nextec Applications, Inc. TextilesProcess Industries Nextec Applications, Inc. designs and manufactures fabrics for outdoor gear, performance apparel, industrial, and protective product markets. It offers absorbing fabrics; wind resistant, abrasion resistant, and fast dry fabrics; blast mitigation systems; fire retardant fabrics; and protective products. The company was founded by Peter Ellman in 1994 and is headquartered in Greenwich, CT. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Stratagene Corp.
Stratagene Corp. Medical SpecialtiesHealth Technology Stratagene Corp. researches, develops and markets diagnostic products and technologies for life science research. The company's products are used in the research of amplification, cell biology, cloning, microarrays, nucleic acid analysis, protein function and analysis, and quantitative PCR. Its clients include the industrial and government research sectors. The firm sells its products in more than 60 countries. Stratagene was founded in 1984 and is located in La Jolla, CA. | Health Technology |
Nextec Applications, Inc.
Nextec Applications, Inc. TextilesProcess Industries Nextec Applications, Inc. designs and manufactures fabrics for outdoor gear, performance apparel, industrial, and protective product markets. It offers absorbing fabrics; wind resistant, abrasion resistant, and fast dry fabrics; blast mitigation systems; fire retardant fabrics; and protective products. The company was founded by Peter Ellman in 1994 and is headquartered in Greenwich, CT. | Process Industries |
Certis Oncology Solutions, Inc.
Certis Oncology Solutions, Inc. BiotechnologyHealth Technology Certis Oncology Solutions, Inc. is a precision oncology and translational science company that partners with oncology therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. The company is based in San Diego, CA. The company uses their proprietary artificial intelligence/machine learning platform and more clinically relevant, patient-derived tumor models to bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy. Certis operates a CLIA-certified laboratory in Sorrento Valley, the heart of the life sciences industry. The company was founded in 2016, and the CEO is Peter Ellman. | Health Technology |
